Form 4: Envoy Medical Director Mona Chetan Patel Acquires Shares and Options

Director Mona Chetan Patel of Envoy Medical, Inc. acquired 2,500 shares of Class A Common Stock and was granted options for 25,000 shares.

Summary

• Mona Chetan Patel, a director at Envoy Medical, Inc., purchased 2,500 shares of Class A Common Stock at a price of $2.2795 per share on November 20, 2024.
• Following this transaction, Ms. Patel directly owns 7,500 shares of Class A Common Stock.
• Ms. Patel was also granted options to purchase 25,000 shares of Class A Common Stock at an exercise price of $2.40 per share.
• These options vest over time, with 6,250 shares vesting on October 15, 2024, and the remaining 18,750 shares vesting pro rata over 36 months.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction by a company director, which is generally viewed as neutral to slightly positive. The purchase of shares and granting of options suggests confidence in the company's future.

Positives

• The director's purchase of shares could be seen as a positive sign of confidence in the company.
• The granting of stock options aligns the director's interests with those of the shareholders.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are a standard practice for all publicly traded companies in the US.
• The level of detail provided in this filing is consistent with SEC requirements.
• The vesting schedule for the stock options is a common practice for incentivizing directors and employees.

Stakeholder Impact

• The purchase of shares by a director may increase investor confidence.
• The granting of stock options aligns the director's interests with those of the shareholders.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Options, Class A Common Stock, Director, Envoy Medical, COCH, Insider Trading